Interestingly, in 5/9 genes (55.5%), i.e., ABHD2, DICER1, GSK3B, NR3C1, and NFIB mutations were localized to functional domains of their corresponding proteins, which suggest them to be highly critical genes for prostate cancers (Figure 4B). Here, DICER1 is linked to prostate carcinoma.